LAM
BIO icon

LECAP Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

LECAP Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,600
Closed -$390K – 295
2025
Q1 		$390K Buy
1,600
+48
+3% +$14.4K 0.09% 254
2024
Q4 		$510K Buy
+1,552
New +$527K 0.14% 221
2024
Q2 		– Sell
-2,438
Closed -$843K – 322
2024
Q1 		$843K Sell
2,438
-2,487
-50% -$818K 0.18% 209
2023
Q4 		$1.59M Buy
+4,925
New +$1.54M 0.58% 49

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

LECAP Asset Management's BIO Position: Q2 2025 in Review

LECAP Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 1,600 shares — an estimated $390K sold.

LECAP Asset Management first reported a position in BIO in Q4 2023 and held it in 4 quarters. The position peaked at $1.59M in Q4 2023. 383 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • LECAP Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • LECAP Asset Management sold 1,600 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $390K.
  • LECAP Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and held it in 4 quarters.
  • LECAP Asset Management's Bio-Rad Laboratories Class A position peaked at $1.59M in Q4 2023.
  • 383 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on LECAP Asset Management's 13F filing for Q2 2025, filed 21 Jul 2025.